Smoking cessation - bupropion and nicotine replacement therapy (replaced by PH10)
The clinical effectiveness and cost effectiveness of bupropion (Zyban) and Nicotine Replacement Therapy for smoking cessation
Summary
This guidance has been replaced by PH10 Smoking cessation services
Guidance documents
Implementing this guidance
We will consult on our review plans for this guidance in March 2005
About this guidance
Technology appraisals TA39
Issued: March 2002